TWST

Twist Bioscience Corp

114.22

Nov 12 • 3:59 PM ET -8.37 (-6.83%)

113.02

Aftermarket • 7:58 PM ET -1.20 (-1.05%)

Healthcare Biotechnology USA Mid NASD

Today, 4:45 PMTwist Bioscience beats fiscal Q4 estimates with $126.6M revenue, up 28% YoY, posts $2.2M adjusted EBITDA, forecasts FY revenue of $550M-$560M

Peers: MRVI A DNA TECH DHR ILMN QGEN TMO CDXS TXG

| Held by: VTI VB IWM ARKE ARKK VBK ARKG XBI VXF IWO

Scroll to Statements

Index	RUT
Market Cap	7.52B
Enterprise Value	7.45B
Income	-136.72M
Sales	431.80M
Book/sh	7.11
Cash/sh	2.53
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	979
IPO	Oct 31, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	17.41
P/B	16.06
P/C	45.07
P/FCF	-
EV/EBITDA	-
EV/Sales	17.24
Quick Ratio	2.38
Current Ratio	2.67
Debt/Eq	0.21
LT Debt/Eq	0.19
Option/Short	Yes / Yes

EPS (ttm)	-2.22
EPS next Y	-1.00
EPS next Q	-0.38
EPS this Y	35.34%
EPS next Y	26.01%
EPS next 5Y	48.13%
EPS past 3/5Y	31.51% 18.31%
Sales past 3/5Y	22.76% 33.11%
EPS Y/Y TTM	-53.86%
Sales Y/Y TTM	19.19%
EPS Q/Q	-268.48%
Sales Q/Q	23.24%
Earnings	Nov 12 BMO
EPS/Sales Surpr.	17.33% 2.51%

Insider Own	2.77%
Insider Trans	-35.65%
Inst Own	118.50%
Inst Trans	4.37%
ROA	-20.78%
ROE	-29.59%
ROIC	-25.76%
Gross Margin	51.97%
Oper. Margin	-31.91%
Profit Margin	-31.66%
SMA20	-18.48%
SMA50	-24.14%
SMA200	22.97%
Trades

Shs Outstand	65.83M
Shs Float	64.01M
Short Float	15.37%
Short Ratio	4.17
Short Interest	9.84M
52W High	219.71 -48.01%
52W Low	23.30 390.21%
Volatility	14.96% 11.69%
ATR (14)	17.57
RSI (14)	38.70
Beta	2.23
Rel Volume	2.25
Avg Volume	2.36M
Volume	5,303,625

Perf Week	-5.30%
Perf Month	-22.91%
Perf Quarter	-3.67%
Perf Half Y	115.71%
Perf YTD	260.09%
Perf Year	258.39%
Perf 3Y	577.06%
Perf 5Y	-1.94%
Perf 10Y	-
Recom	2.00
Target Price	155.91
Prev Close	122.59
Price	114.22
Change %	-6.83%

Consensus

Buy

Avg. Price Target

$155.91

Implied Upside

+36.5%

Analysts16incl. previous ratings

Rating Distribution11 Buy · 3 Hold · 2 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 08, 2026	Initiated	JJefferies	Hold	$150	+31.3%
Sep 09, 2026	Initiated	UUBS	Neutral	$144	+26.1%
Sep 09, 2026	Initiated	BBWS Financial	Sell	$45	-60.6%
Jul 06, 2026	Downgrade	EEvercore ISI	Outperform → In-line	$102	-10.7%
Jun 15, 2026	Initiated	CCanaccord Genuity	Buy	$90	-21.2%
May 05, 2026	Upgrade	LLeerink Partners	Market Perform → Outperform	$70	-38.7%
Nov 04, 2025	Initiated	SStephens	Overweight	$41	-64.1%
Dec 13, 2024	Initiated	WWolfe Research	Outperform	$60	-47.5%
Jun 04, 2024	Initiated	GGuggenheim	Buy	$53	-53.6%
Jan 17, 2024	Upgrade	GGoldman	Neutral → Buy	$25 → $45	-60.6%
Sep 27, 2023	Initiated	BBerenberg	Buy	$27	-76.4%
Jan 05, 2023	Initiated	BScotiabank	Sector Outperform	$33	-71.1%
Jan 03, 2023	Upgrade	EEvercore ISI	In-line → Outperform	$28 → $36	-68.5%
Mar 02, 2022	Resumed	CCowen	Outperform
Oct 15, 2021	Resumed	CCowen	Outperform
Jun 29, 2021	Initiated	WWilliam Blair	Outperform
Jun 04, 2021	Initiated	GGoldman	Neutral	$110	-3.7%
Apr 12, 2021	Initiated	PPiper Sandler	Overweight	$150	+31.3%
Feb 05, 2021	Downgrade	JJP Morgan	Neutral → Underweight	$100	-12.4%
Jan 04, 2021	Downgrade	EEvercore ISI	Outperform → In-line

Today 03:59PM	Twist Bioscience earnings analysis: questions answered and next catalysts (Investing.com) -6.83%
10:44AM	Twist Bioscience Beats And Exits FY26 At 28% Growth, But An In-Line FY27 Guide Implies Slower Growth Ahead (Earnings Whispers)
08:54AM	Twist Bioscience Crashes Despite Quarterly Beat, Solid Guidance (Investor's Business Daily)
08:40AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press)
06:15AM	Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results (Business Wire)
07:00AM	Loading…
Nov-11-26 07:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire) -7.22%
Nov-09-26 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire) +12.05%
Nov-04-26 04:25PM	Twist Bioscience Faces A Lofty Bar After A 72% Rally On AI Drug-Discovery Momentum (Earnings Whispers) -15.41%
Nov-03-26 03:05PM	Notice of Proposed Derivative Settlement: Twist Bioscience Corporation (Business Wire) +8.73%
Oct-29-26 08:00AM	Twist Bioscience Launches MRD Express with Rapid Turnaround Time (Business Wire)
Oct-28-26 08:00AM	Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies (Business Wire) +8.51%
Oct-26-26 08:00AM	Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026 (Business Wire)
Oct-13-26 09:23AM	FTC seeks contempt finding against Martin Shkreli for alleged pharma ban violation (Investing.com)
Oct-06-26 01:09PM	NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue Beat (TIKR) -18.55%
08:16AM	Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies Unloads $18M Worth Of TWST Shares (Stocktwits)
02:44AM	Loading…
Oct-05-26 02:44AM	Cathie Woods ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year (Stocktwits) +8.66%
Oct-01-26 12:11PM	AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment (PR Newswire)
Sep-25-26 06:29PM	What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
12:36AM	Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen. (TIKR)
Sep-17-26 05:44PM	TWST Stock Hits Multi-Year High, But Pharma Bro Martin Shkreli Calls Twist A Short (Stocktwits) +8.73% +7.35%
01:56PM	HAE, TWST Stocks Jump To Over 5-Year Highs Whats Driving The Gains Today? (Stocktwits)
Sep-16-26 08:00AM	Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery (Business Wire)
Sep-09-26 08:00AM	Twist Bioscience to Present at Baird 2026 Global Healthcare Conference (Business Wire)
Sep-03-26 08:55AM	AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 (PR Newswire)
Sep-01-26 06:54AM	What Is Cathie Wood Buying Now? Nvidia, SpaceX And Crypto Stocks Led ARKs August Trades While Cutting These Growth Stocks (Stocktwits)
Aug-19-26 01:21AM	Pharma Bro Martin Shkreli Slams Anthropics Claude Drug-Discovery Claims: This Is Not Impressive Work (Stocktwits) +22.64%
Aug-04-26 11:45PM	Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock (Business Wire) +15.65%
04:01PM	Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock (Business Wire)
08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Aug-03-26 03:00PM	Twist Bioscience Corp (TWST) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven ... (GuruFocus.com) +10.39%
09:38AM	Loading…
09:38AM	Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble (Investor's Business Daily)
08:33AM	Twist Bioscience Shares Decline Following Quarterly Earnings Miss (InvestorsHub)
07:21AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press)
07:15AM	Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results (Business Wire)
Jul-20-26 12:06PM	Cathie Wood Dumps $39 Million Worth of AMD Stock (GuruFocus.com) -6.82%
Jul-15-26 08:00AM	Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026 (Business Wire)
07:41AM	Cathie Woods ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again (Stocktwits)
Jul-13-26 12:52PM	Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group (GuruFocus.com)
Jul-10-26 08:57AM	Cathie Wood Dumps AMD, Doubles Down on Meta Stock (GuruFocus.com)
Jun-29-26 07:53PM	XBI Ignored The Market's Downturn (Trefis)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com) +6.07%
09:42AM	Datadog upgraded, Accenture downgraded: Wall Street's top analyst calls (The Fly)
Jun-12-26 03:01AM	Is Cathie Wood Making Room For SpaceX? ARK Funds Dump Over $200M Across 20 Stocks Ahead Of Mega IPO (Stocktwits)
Jun-11-26 09:38AM	SpaceX initiated, Intel upgraded: Wall Street's top analyst calls (The Fly) +9.27%
May-27-26 08:00AM	Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference (Business Wire)
May-26-26 09:13AM	Cathie Wood Is Dumping AMD and TSMC Stock. Here's What She's Buying Instead (GuruFocus.com) +7.10%
May-05-26 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-04-26 07:23AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press) -6.97%
07:20AM	Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences (Business Wire)
07:15AM	Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results (Business Wire)
Apr-21-26 08:00AM	Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026 (Business Wire)
Feb-24-26 03:52PM	ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025 (Benzinga)
Feb-18-26 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-17-26 07:00AM	Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement (Business Wire) +7.68%
Feb-10-26 08:00AM	Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes (Business Wire)
Feb-09-26 12:06PM	Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification (MarketBeat)
Feb-03-26 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-02-26 10:02PM	Twist Bioscience Corporation (TWST): A Bull Case Theory (Insider Monkey) +13.98%
02:27PM	Why Is Twist Bioscience Stock Soaring Monday? (Benzinga)
02:00PM	Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:52PM	Twist Bioscience Q1 Earnings Call Highlights (MarketBeat)
08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:21AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results (Business Wire)
Jan-27-26 10:00AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-26-26 10:00AM	Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jan-12-26 08:00AM	Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue (Business Wire) +7.70%
Dec-31-25 06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:48PM	Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) (Insider Monkey)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-22-25 10:20PM	New Product Launch Strengthens Bull Case for Twist?Bioscience (?TWST) (Insider Monkey) +7.84%
Dec-18-25 08:00AM	Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference (Business Wire)
Dec-12-25 01:15PM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Dec-04-25 08:00AM	Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research (Business Wire) +5.26%
Nov-18-25 09:40AM	Company News for Nov 18, 2025 (Zacks)
04:45AM	Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT (Insider Monkey)
Nov-17-25 10:13AM	Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? (Insider Monkey)
Nov-14-25 02:01PM	Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -10.13%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:34AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-13-25 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -6.18%
Nov-12-25 08:10AM	Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:20PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 09:11AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More (24/7 Wall St.)
08:00AM	Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference (Business Wire)
Nov-03-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-24-25 06:20AM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire) +7.16%
Oct-23-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 (Business Wire)
Oct-22-25 08:53AM	Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 (Insider Monkey) -6.98%
Oct-06-25 08:00AM	Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System (Business Wire)
Oct-02-25 02:00PM	Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design (Business Wire)
Sep-24-25 04:47AM	Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience (Zacks)
Sep-23-25 09:23AM	5 Biotech Stocks Worth Adding to Your Portfolio Now (Zacks)
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
Sep-17-25 02:18PM	TD Cowen Reaffirms Buy on Twist Bioscience (TWST) Amid Scaling and Margin Gains (Insider Monkey)
Sep-03-25 08:00AM	Twist Bioscience to Present at Baird 2025 Global Healthcare Conference (Business Wire)
Sep-02-25 08:00AM	Twist Bioscience Collaborates with Synthetic Design Lab (Business Wire)
Aug-19-25 08:00AM	Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution (Business Wire)
Aug-13-25 07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cho Dennis	See Remarks	Nov 03 '26	Sale	135.40	949	128,496	62,840	Nov 05 04:05 PM
Finn Patrick John	President and COO	Nov 03 '26	Sale	135.40	2,565	347,306	180,278	Nov 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Nov 03 '26	Sale	135.40	4,573	619,193	558,187	Nov 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 03 '26	Sale	135.40	148	20,039	42,769	Nov 05 04:05 PM
Green Paula	SVP of Human Resources	Nov 03 '26	Sale	135.40	1,007	136,350	105,625	Nov 05 04:05 PM
WERNER ROBERT F.	Officer	Nov 03 '26	Proposed Sale	135.40	148	20,039		Nov 03 03:24 PM
Finn Patrick John	Officer	Nov 03 '26	Proposed Sale	135.40	2,565	347,305		Nov 03 03:21 PM
Cho Dennis	Officer	Nov 03 '26	Proposed Sale	135.40	949	128,496		Nov 03 03:21 PM
Leproust Emily M.	Officer	Nov 03 '26	Proposed Sale	135.40	4,573	619,192		Nov 03 03:19 PM
Green Paula	Officer	Nov 03 '26	Proposed Sale	135.40	1,007	136,350		Nov 03 03:16 PM
Finn Patrick John	President and COO	Oct 23 '26	Sale	134.59	2,245	302,152	182,843	Oct 27 04:05 PM
Finn Patrick John	Officer	Oct 23 '26	Proposed Sale	134.59	2,245	302,153		Oct 23 03:15 PM
Laponis Adam	Chief Financial Officer	Oct 09 '26	Sale	156.30	2,462	384,823	98,114	Oct 13 04:05 PM
Laponis Adam	Officer	Oct 09 '26	Proposed Sale	156.30	2,462	384,823		Oct 09 03:12 PM
Leproust Emily M.	Chief Executive Officer	Oct 05 '26	Sale	202.15	4,548	919,374	562,760	Oct 07 04:05 PM
Leproust Emily M.	Officer	Oct 05 '26	Proposed Sale	202.15	4,548	919,374		Oct 05 04:39 PM
Laponis Adam	Chief Financial Officer	Oct 02 '26	Sale	188.88	8,057	1,521,838	100,576	Oct 05 04:05 PM
Green Paula	SVP of Human Resources	Oct 02 '26	Sale	188.88	10,088	1,905,462	106,632	Oct 05 04:05 PM
Finn Patrick John	President and COO	Oct 02 '26	Sale	188.88	25,714	4,856,963	185,088	Oct 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 02 '26	Sale	188.88	45,736	8,638,799	567,308	Oct 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 01 '26	Sale	200.00	655	131,000	613,044	Oct 05 04:05 PM
Cho Dennis	See Remarks	Oct 02 '26	Sale	188.88	9,514	1,797,042	63,789	Oct 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Oct 02 '26	Sale	188.88	1,482	279,926	42,917	Oct 05 04:05 PM
Green Paula	Officer	Oct 02 '26	Proposed Sale	188.88	10,088	1,905,460		Oct 02 04:50 PM
WERNER ROBERT F.	Officer	Oct 02 '26	Proposed Sale	188.88	1,482	279,926		Oct 02 04:50 PM
Cho Dennis	Officer	Oct 02 '26	Proposed Sale	188.88	9,514	1,797,040		Oct 02 04:41 PM
Leproust Emily M.	Officer	Oct 02 '26	Proposed Sale	188.88	45,736	8,638,789		Oct 02 04:38 PM
Laponis Adam	Officer	Oct 02 '26	Proposed Sale	188.88	8,057	1,521,837		Oct 02 04:34 PM
Finn Patrick John	Officer	Oct 02 '26	Proposed Sale	188.88	25,714	4,856,958		Oct 02 04:17 PM
Leproust Emily M.	Officer	Oct 01 '26	Proposed Sale	200.00	655	131,000		Oct 01 04:27 PM
Leproust Emily M.	Chief Executive Officer	Sep 24 '26	Sale	177.38	5,203	922,907	613,699	Sep 25 04:05 PM
Leproust Emily M.	Officer	Sep 24 '26	Proposed Sale	177.38	5,203	922,906		Sep 24 05:45 PM
Cho Dennis	See Remarks	Sep 21 '26	Sale	165.49	348	57,591	73,303	Sep 23 04:08 PM
Green Paula	SVP of Human Resources	Sep 21 '26	Sale	165.49	294	48,654	116,720	Sep 23 04:07 PM
Leproust Emily M.	Chief Executive Officer	Sep 21 '26	Sale	165.49	1,687	279,183	618,902	Sep 23 04:07 PM
Leproust Emily M.	Officer	Sep 21 '26	Proposed Sale	165.49	1,687	279,184		Sep 21 04:54 PM
Green Paula	Officer	Sep 21 '26	Proposed Sale	165.49	294	48,654		Sep 21 04:53 PM
Cho Dennis	Officer	Sep 21 '26	Proposed Sale	165.49	348	57,591		Sep 21 04:52 PM
Leproust Emily M.	Chief Executive Officer	Sep 17 '26	Option Exercise	20.21	208,708	4,218,324	977,135	Sep 21 04:05 PM
Leproust Emily M.	Chief Executive Officer	Sep 17 '26	Sale	157.99	356,546	56,330,724	620,589	Sep 21 04:05 PM
Leproust Emily M.	Officer	Sep 17 '26	Proposed Sale	151.43	295,037	44,677,453		Sep 17 04:44 PM
Leproust Emily M.	Officer	Sep 17 '26	Proposed Sale	151.43	61,509	9,314,308		Sep 17 04:34 PM
Cho Dennis	See Remarks	Sep 08 '26	Sale	122.62	412	50,521	73,651	Sep 10 04:00 PM
Green Paula	SVP of Human Resources	Sep 08 '26	Sale	122.62	907	111,220	117,014	Sep 10 04:00 PM
Leproust Emily M.	Chief Executive Officer	Sep 08 '26	Sale	122.62	2,302	282,280	768,427	Sep 10 04:00 PM
WERNER ROBERT F.	Chief Accounting Officer	Sep 08 '26	Sale	122.62	238	29,185	44,399	Sep 10 04:00 PM
Leproust Emily M.	Officer	Sep 08 '26	Proposed Sale	122.62	2,302	282,280		Sep 08 03:17 PM
Green Paula	Officer	Sep 08 '26	Proposed Sale	122.62	907	111,220		Sep 08 03:15 PM
WERNER ROBERT F.	Officer	Sep 08 '26	Proposed Sale	122.62	238	29,184		Sep 08 03:12 PM
Cho Dennis	Officer	Sep 08 '26	Proposed Sale	122.62	412	50,521		Sep 08 03:11 PM
Leproust Emily M.	Chief Executive Officer	Aug 25 '26	Sale	151.98	41,570	6,317,760	770,729	Aug 27 04:05 PM
Leproust Emily M.	Officer	Aug 25 '26	Proposed Sale	151.98	41,570	6,317,761		Aug 25 05:02 PM
Cho Dennis	See Remarks	Aug 21 '26	Sale	139.07	1,598	222,227	74,063	Aug 25 04:05 PM
Finn Patrick John	President and COO	Aug 21 '26	Sale	139.07	4,046	562,661	210,802	Aug 25 04:05 PM
Green Paula	SVP of Human Resources	Aug 21 '26	Sale	139.07	1,360	189,130	117,921	Aug 25 04:05 PM
Laponis Adam	Chief Financial Officer	Aug 21 '26	Sale	139.07	1,965	273,265	108,633	Aug 25 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 21 '26	Sale	139.07	6,639	923,259	812,299	Aug 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 24 '26	Sale	140.77	854	120,220	44,637	Aug 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 21 '26	Sale	139.07	669	93,035	45,491	Aug 25 04:05 PM
WERNER ROBERT F.	Officer	Aug 24 '26	Proposed Sale	140.77	854	120,220		Aug 24 03:23 PM
Cho Dennis	See Remarks	Aug 19 '26	Sale	129.75	14,205	1,843,099	75,661	Aug 21 04:05 PM
Leproust Emily M.	Officer	Aug 21 '26	Proposed Sale	139.07	6,639	923,262		Aug 21 04:02 PM
Green Paula	Officer	Aug 21 '26	Proposed Sale	139.07	1,360	189,130		Aug 21 03:51 PM
Laponis Adam	Officer	Aug 21 '26	Proposed Sale	139.07	1,965	273,265		Aug 21 03:49 PM
Cho Dennis	Officer	Aug 21 '26	Proposed Sale	139.07	1,598	222,228		Aug 21 03:39 PM
WERNER ROBERT F.	Officer	Aug 21 '26	Proposed Sale	139.07	669	93,035		Aug 21 03:24 PM
Finn Patrick John	Officer	Aug 21 '26	Proposed Sale	139.07	4,046	562,663		Aug 21 03:20 PM
Finn Patrick John	President and COO	Aug 18 '26	Option Exercise	67.85	23,355	1,584,637	293,033	Aug 20 04:05 PM
Finn Patrick John	President and COO	Aug 18 '26	Sale	117.64	78,355	9,217,607	214,678	Aug 20 04:05 PM
Cho Dennis	Officer	Aug 19 '26	Proposed Sale	129.75	14,205	1,843,099		Aug 19 02:25 PM
Finn Patrick John	Officer	Aug 18 '26	Proposed Sale	121.61	78,355	9,528,752		Aug 18 10:42 AM
BLAKE KATRYN	Director	Aug 12 '26	Sale	122.88	2,240	275,251	17,208	Aug 14 04:12 PM
Leproust Emily M.	Chief Executive Officer	Aug 12 '26	Option Exercise	26.66	19,952	531,920	838,890	Aug 14 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 12 '26	Sale	125.08	19,952	2,495,508	818,938	Aug 14 04:05 PM
Leproust Emily M.	Officer	Aug 12 '26	Proposed Sale	125.08	19,952	2,495,507		Aug 12 04:29 PM
Leproust Emily M.	Chief Executive Officer	Aug 10 '26	Option Exercise	26.66	113,318	3,021,058	932,256	Aug 12 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 10 '26	Sale	125.16	113,318	14,183,051	818,938	Aug 12 04:05 PM
BLAKE KATRYN	Director	Aug 12 '26	Proposed Sale	122.88	2,240	275,250		Aug 12 04:00 PM
CHESS ROBERT	Director	Aug 07 '26	Option Exercise	11.89	18,417	218,978	39,501	Aug 11 04:05 PM
CHESS ROBERT	Director	Aug 07 '26	Sale	110.89	18,417	2,042,261	21,084	Aug 11 04:05 PM
Leproust Emily M.	Officer	Aug 10 '26	Proposed Sale	125.16	113,318	14,183,057		Aug 10 06:49 PM
Cho Dennis	See Remarks	Aug 05 '26	Sale	109.75	14,205	1,558,999	89,866	Aug 07 04:05 PM
CHESS ROBERT	Director	Aug 07 '26	Proposed Sale	110.89	18,417	2,042,261		Aug 07 11:04 AM
Finn Patrick John	President and COO	Aug 03 '26	Sale	85.32	2,888	246,408	269,678	Aug 05 04:05 PM
Green Paula	SVP of Human Resources	Aug 03 '26	Sale	85.32	1,133	96,669	119,281	Aug 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 03 '26	Sale	85.32	5,101	435,223	818,938	Aug 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 03 '26	Sale	85.32	167	14,249	46,160	Aug 05 04:05 PM
Cho Dennis	See Remarks	Aug 03 '26	Sale	85.32	1,070	91,294	104,071	Aug 05 04:05 PM
Cho Dennis	Officer	Aug 05 '26	Proposed Sale	109.75	14,205	1,558,999		Aug 05 01:50 PM
Leproust Emily M.	Officer	Aug 03 '26	Proposed Sale	85.32	5,101	435,223		Aug 03 04:08 PM
Green Paula	Officer	Aug 03 '26	Proposed Sale	85.32	1,133	96,669		Aug 03 03:53 PM
Cho Dennis	Officer	Aug 03 '26	Proposed Sale	85.32	1,070	91,294		Aug 03 03:49 PM
Finn Patrick John	Officer	Aug 03 '26	Proposed Sale	85.32	2,888	246,408		Aug 03 03:39 PM
WERNER ROBERT F.	Officer	Aug 03 '26	Proposed Sale	85.32	167	14,249		Aug 03 03:33 PM
Finn Patrick John	President and COO	Jul 23 '26	Sale	93.89	2,238	210,133	272,566	Jul 27 04:05 PM
Finn Patrick John	Officer	Jul 23 '26	Proposed Sale	93.89	2,238	210,133		Jul 23 03:14 PM
Laponis Adam	Chief Financial Officer	Jul 09 '26	Sale	94.33	2,399	226,307	110,276	Jul 13 04:05 PM
Laponis Adam	Officer	Jul 09 '26	Proposed Sale	94.33	2,399	226,306		Jul 09 03:15 PM
Leproust Emily M.	Chief Executive Officer	Jun 25 '26	Sale	95.00	18,880	1,793,600	824,039	Jun 26 04:41 PM
Cho Dennis	See Remarks	Jun 24 '26	Sale	89.75	14,205	1,274,899	105,141	Jun 26 04:05 PM

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Co-FounderDr. Emily Marine Leproust Ph.D.

President & COODr. Patrick John Finn Ph.D.

Chief Financial OfficerMr. Adam Laponis

Chief Legal Officer & Corporate SecretaryMr. Dennis Cho J.D.

Senior Vice President of Human ResourcesMs. Paula Green

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

TWST

Twist Bioscience Corp

Upgrade your Finviz experience

All the Features.
Half the Price.